Sanyou Biopharmaceuticals Co.
Latest round
- Series B
Last raised
- Aug 2022
Total raised
- Undisclosed
Investors
- 9
About Sanyou Biopharmaceuticals Co.
, Ltd. is a pharmaceutical company that focuses on development of innovative monoclonal antibody drugs, providing therapeutic antibody discovery and relevant technology platforms. The company has established global business centers across Asia, North America, and Europe and has filed over 130 invention patents. It has also obtained over 10 national and international qualifications and system certifications, including National High-Tech Enterprise, Shanghai “Specialized and Innovative” Enterprise, ISO9001, and ISO27001., Ltd., Ltd. from Haier Capital. The company has built an integrated drug development platform, mainly including innovative antibody drugs, target-to-PCC drugs, PCC-to-IND drugs and other research and development platforms, the innovative antibody drug discovery platform include integrated protein and antigen preparation technology, systematic antibody drug functional screening technology, large-capacity phage display full antibody library technology, innovative antibody engineering technology, diversified antibody production technology and integrated genetic engineering antibody library technology, and has self-develop a COVID-19 proteins and antibodies in 2020. The company also provides high-quality proteins, antibodies, cell lines and detection reagents. The company generates revenue from providing integrated antibody drug development platforms., Ltd.'s governance structure and deepen industrial synergy.
Who invested in Sanyou Biopharmaceuticals Co.
9 investors across 4 rounds
See all investors in Sanyou Biopharmaceuticals Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sanyou Biopharmaceuticals Co.
Who invested in Sanyou Biopharmaceuticals Co.?
Sanyou Biopharmaceuticals Co. has 9 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sanyou Biopharmaceuticals Co. raised?
Sanyou Biopharmaceuticals Co. has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Sanyou Biopharmaceuticals Co. last raise money?
Sanyou Biopharmaceuticals Co.'s most recent round on record is a Series B, in Aug 2022.
What does Sanyou Biopharmaceuticals Co. do?
Sanyou Biopharmaceuticals Co. is a pharmaceuticals company.
Where is Sanyou Biopharmaceuticals Co. headquartered?
Sanyou Biopharmaceuticals Co. is headquartered in Shanghai, China.
Which VCs invest in companies like Sanyou Biopharmaceuticals Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Sanyou Biopharmaceuticals Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Sanyou Biopharmaceuticals Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.